52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
U.S. Centers For Disease Control Director Walensky Says New Report Shows That Increases In Daily Death Rates Slowed Significantly Within 20 Days Of Mask Mandates In Place
J&J Anticipates Fulfilling 10 Million Doses Included In Advance Purchase Agreement With The Government Of Canada By The End Of Q3 2021
Shine Justice Says Ethicon, Johnson & Johnson Mesh Appeal Dismissed
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.
Biotechnology & Drugs
1 Johnson And Johnson Plz
NEW BRUNSWICK, NJ
Chairman of the Board, Chief Executive Officer
Paulus A. Stoffels
Vice Chairman- Executive Committee, Chief Scientific Officer
Joaquin Boix Duato
Vice Chairman - Executive Committee
Joseph J. Wolk
Chief Financial Officer, Executive Vice President
Peter M. Fasolo
Chief Human Resource Officer, Executive Vice President
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Canada's drug regulator on Friday approved Johnson & Johnson's COVID-19 vaccine, the fourth such shot to be given the green light, as Ottawa brought forward deliveries of millions of Pfizer doses.
Health Canada approves Johnson & Johnson's COVID-19 vaccine - government source Further company coverage: (Reporting by Steve Scherer)
Health Canada will announce the approval of Johnson & Johnson's single-dose COVID-19 vaccine on Friday, CBC News reported, citing sources.
Canada's drug regulator has approved Johnson & Johnson's single-dose COVID-19 vaccine, the Canadian Broadcasting Corp. said on Friday, citing an unidentified source.
Denmark has pushed back the final date for when it expects all Danes to have been fully vaccinated against COVID-19 to July 18 after shipments from Johnson & Johnson and Curevac were delayed, local media reported on Friday, citing ministry documents.
An Australian court on Friday dismissed an appeal by Johnson & Johnson against a ruling that its subsidiary Ethicon had misled patients and surgeons about the risks of its pelvic mesh implants.
Johnson & Johnson has asked the U.S. Supreme Court to hear its appeal of a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in its baby powder and other talc products.
The White House said the federal government in planning to spend $100 million to help the recently announced vaccine partnership between Merck & Co and rival Johnson & Johnson, White House senior adviser Andy Slavitt said on Wednesday.
American Airlines will on Thursday begin providing employees with a limited supply of Johnson & Johnson's single-shot COVID-19 vaccine at Chicago's O'Hare airport, according to a letter sent to Chicago-based employees.
President Joe Biden on Tuesday called on U.S. states to prioritize COVID-19 vaccinations for teachers to ensure children could return to school quickly and safely, and said every educator should receive at least one shot by the end of March.
The United States will have enough COVID-19 vaccine for every American adult by the end of May, President Joe Biden said on Tuesday after Merck & Co agreed to make rival Johnson & Johnson's inoculation.
The United States is using the Defense Production Act to equip drugmaker Merck & Co's plants to make Johnson & Johnson's just approved COVID-19 vaccine, White House press secretary Jen Psaki said on Tuesday.
Merck & Co Inc will help make rival Johnson & Johnson's single-shot COVID-19 vaccine, the Washington Post reported on Tuesday, citing senior officials from U.S. President Joe Biden's administration.
* MERCK WILL HELP MAKE JOHNSON & JOHNSON CORONAVIRUS VACCINE - WASHINGTON POST
Johnson & Johnson is waiting on regulatory approval of a new, larger plant operated by contract manufacturer Catalent Inc to begin large-scale U.S. deliveries of its just-authorized COVID-19 vaccine following initial shipments this week, a top J&J executive said on Monday.
Johnson & Johnson will ship nearly 4 million doses of its newly authorized single-dose COVID-19 vaccine around the United States this week, but a top executive said on Monday that the next round of deliveries is contingent on regulatory approvals at a new plant.
Chile plans to ramp up its purchase of vaccines from China's Sinovac and hopes to sign a deal shortly with Johnson & Johnson, the health minister said on Monday, as the South American nation moves to strengthen its widely lauded coronavirus vaccination campaign.
Chile plans to ramp up its purchase of vaccines from China's Sinovac and hopes to ink a deal shortly with Johnson & Johnson, the health minister said on Monday, as the South American nation moves to strengthen its widely lauded coronavirus vaccination campaign.
Wall Street's major averages rose 1.5% on Monday as bond markets calmed after a month-long selloff, while encouraging updates on the vaccine and stimulus fronts strengthened bets over a swift economic recovery.
Wall Street's major averages opened higher on Monday as bond markets calmed after a month-long selloff, while encouraging updates on the vaccine and stimulus fronts strengthened bets over a swift economic recovery.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.